UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Journal of infectious diseases, ISSN 0022-1899, 01/2016, Volume 213, Issue 1, pp. 105 - 111
leishmaniasis; L. guyanensis; Leishmania RNA virus; drug treatment; pentamidine; mutualism exclusive | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Leishmaniasis, Mucocutaneous - epidemiology | Leishmaniavirus | Recurrence | Humans | Pentamidine - therapeutic use | Male | Leishmania guyanensis - drug effects | Antiprotozoal Agents - pharmacology | Leishmaniasis, Mucocutaneous - drug therapy | Leishmania guyanensis - virology | Treatment Failure | Leishmaniasis, Mucocutaneous - virology | Adult | Female | Antiprotozoal Agents - therapeutic use | Cohort Studies | Pentamidine - pharmacology | Treatment outcome | Care and treatment | Relapse | Leishmania | Analysis | Research | Leishmaniasis | Risk factors | Diseases | Index Medicus | Abridged Index Medicus | Antiprotozoal Agents/pharmacology | Leishmaniasis, Mucocutaneous/drug therapy | Leishmaniasis, Mucocutaneous/virology | Life Sciences | Leishmania guyanensis/drug effects | Leishmaniasis, Mucocutaneous/epidemiology | Leishmania guyanensis/virology | Antiprotozoal Agents/therapeutic use | Pentamidine/pharmacology | Pentamidine/therapeutic use
Journal Article
Journal of controlled release, ISSN 0168-3659, 01/2019, Volume 294, pp. 17 - 26
S100B-pentamidine inhibition | Neuroinflammation | Pentamidine | Parkinson's disease | Nose-to-brain delivery | Chitosan coated niosomes | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Male | Brain - metabolism | Parkinsonian Disorders - metabolism | Pentamidine - pharmacokinetics | Parkinsonian Disorders - drug therapy | Antiparkinson Agents - chemistry | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Nasal Mucosa - metabolism | Dopamine - metabolism | Mice, Inbred C57BL | Chitosan - administration & dosage | Pentamidine - administration & dosage | Administration, Intranasal | Antiparkinson Agents - pharmacokinetics | Brain - drug effects | Animals | Anti-Inflammatory Agents - chemistry | Chitosan - chemistry | Parkinsonian Disorders - pathology | Pentamidine - chemistry | Chitosan - pharmacokinetics | Brain - pathology | Drug Liberation | Antiparkinson Agents - administration & dosage | Liposomes | Index Medicus
Journal Article
2017, ISBN 9781421423234, 237 pages
Book
Molecular systems biology, ISSN 1744-4292, 2011, Volume 7, Issue 1, pp. 544 - n/a
drug discovery | chemical genetics | genetic interactions | drug combinations | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Antifungal Agents - pharmacology | Drug Synergism | Pentamidine - pharmacokinetics | Saccharomyces cerevisiae - metabolism | Drug Interactions | Saccharomyces cerevisiae - genetics | Antifungal Agents - pharmacokinetics | Tacrolimus - pharmacology | Biological Availability | Saccharomyces cerevisiae - drug effects | Tacrolimus - pharmacokinetics | Pentamidine - pharmacology | Drugs | Organic chemistry | Fungicides | Tacrolimus | Genes | Relative abundance | Pentamidine | Bioavailability | Synergism | Index Medicus
Journal Article
Nanotechnology, ISSN 0957-4484, 08/2019, Volume 30, Issue 45, pp. 455102 - 455102
nanoparticles | oral administration | leishmaniasis | pentamidine | poly(dl-lactic-co-glycolic) acid | Physical Sciences | Materials Science | Nanoscience & Nanotechnology | Technology | Materials Science, Multidisciplinary | Science & Technology - Other Topics | Physics | Science & Technology | Physics, Applied | Nanoparticles - chemistry | Administration, Oral | Parasite Load | Polylactic Acid-Polyglycolic Acid Copolymer - chemistry | Biological Availability | Leishmaniasis - drug therapy | Antiprotozoal Agents - chemistry | Pentamidine - administration & dosage | Particle Size | Pentamidine - pharmacokinetics | Antiprotozoal Agents - pharmacokinetics | Organ Size - drug effects | Animals | Pentamidine - chemistry | Antiprotozoal Agents - administration & dosage | Leishmaniasis - parasitology | Mice | Mice, Inbred BALB C | Disease Models, Animal | Index Medicus
Journal Article
Canadian Medical Association journal (CMAJ), ISSN 0820-3946, 01/2021, Volume 193, Issue 1, p. E34
Journal Article
British journal of pharmacology, ISSN 0007-1188, 08/2017, Volume 174, Issue 15, pp. 2576 - 2590
TORSADES-DE-POINTES | CURRENT I-K1 | CARDIAC REPOLARIZATION | HUMAN AFRICAN TRYPANOSOMIASIS | POTASSIUM CURRENT | ATRIOVENTRICULAR-BLOCK | IONIC MECHANISMS | III DRUGS | TRANSMURAL CONDUCTION | UP-REGULATION | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Atrial Fibrillation - chemically induced | Administration, Intravenous | Animals | Humans | Dogs | Female | Pentamidine - administration & dosage | Pentamidine - analogs & derivatives | Goals | Disease Models, Animal | Pentamidine - pharmacology | Muscles | Heart beat | Goats | Analysis | Atrial fibrillation | Cardiac arrhythmia | Animal models | Cardiomyocytes | Pentamidine | Skeletal muscle | Heart rate | Infusion | Fibrillation | Inhibitors | Sinus | Bioaccumulation | Rectifiers | Refractory period | Electrocardiography | Plasma levels | Ventricle | Heart diseases | Prolongation | Index Medicus | Research Papers | Research Paper
Journal Article
Biochimie, ISSN 0300-9084, 2008, Volume 90, Issue 7, pp. 999 - 1014
Antiparasitic drugs | Kinetoplast DNA | DNA topology | Heterocyclic diamidines | DNA binding | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Humans | Models, Molecular | Pentamidine - analogs & derivatives | Nucleic Acid Conformation - drug effects | Drug Delivery Systems | Animals | Heterocyclic Compounds - chemistry | Pentamidine - chemistry | DNA, Protozoan - drug effects | Antiparasitic Agents - pharmacology | Eukaryota - drug effects | DNA, Protozoan - chemistry | Antiparasitic Agents - chemistry | Pentamidine - pharmacology | Index Medicus
Journal Article
Future microbiology, ISSN 1746-0913, 09/2011, Volume 6, Issue 9, pp. 1037 - 1047
nitroreductase | eflornithine transporter | HAPT1 | P2 transporter | treatment failure | human African trypanosomiasis | drug resistance | sleeping sickness | Life Sciences & Biomedicine | Microbiology | Science & Technology | Trypanosomiasis, African - drug therapy | Humans | Pentamidine - therapeutic use | Eflornithine - pharmacokinetics | Eflornithine - pharmacology | Eflornithine - therapeutic use | Trypanocidal Agents - pharmacokinetics | Drug Resistance - genetics | Nifurtimox - pharmacology | Animals | Protozoan Proteins - metabolism | Nifurtimox - pharmacokinetics | Trypanocidal Agents - pharmacology | Trypanosoma - drug effects | Trypanosoma - metabolism | Treatment Failure | Membrane Transport Proteins - metabolism | Trypanocidal Agents - therapeutic use | Pentamidine - metabolism | Nifurtimox - therapeutic use | Trypanosoma - physiology | Pentamidine - pharmacology | International cooperation | nifurtimox | Central nervous system | Plasma membranes | Amino acids | Pentamidine | Parasites | Drug resistance | African trypanosomiasis | Eflornithine
Journal Article
Bioorganic & medicinal chemistry, ISSN 0968-0896, 08/2015, Volume 23, Issue 15, pp. 4489 - 4500
Ifenprodil | Polyamine | Radioligand binding | Bisbenzamidine | Pentamidine | Coupling | NMDA receptor | Alkylation | Rat brain | Molecular docking | Protein Structure, Tertiary | Piperidines - chemistry | Piperidines - metabolism | Dizocilpine Maleate - chemistry | Receptors, N-Methyl-D-Aspartate - metabolism | Pentamidine - chemical synthesis | Rats | Piperazines - metabolism | Pentamidine - analogs & derivatives | Piperazines - chemistry | Tritium - chemistry | Dizocilpine Maleate - metabolism | Brain - metabolism | Animals | Receptors, N-Methyl-D-Aspartate - chemistry | Molecular Docking Simulation | Pentamidine - metabolism | Binding Sites | Brain | Index Medicus
Journal Article
British journal of pharmacology, ISSN 0007-1188, 07/2013, Volume 169, Issue 6, pp. 1322 - 1334
hERG | pentamidine | chemical substructures | drug‐induced trafficking defects | KIR2.1 | Long QT syndrome | ion channel trafficking | safety pharmacology | dofetilide | drug-induced trafficking defects | 2.1 | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Membrane Transport Modulators - chemistry | Arrhythmias, Cardiac - chemically induced | Anti-Arrhythmia Agents - pharmacology | Humans | Ether-A-Go-Go Potassium Channels - metabolism | Structure-Activity Relationship | ERG1 Potassium Channel | Membrane Transport Modulators - pharmacology | HEK293 Cells | Cell Membrane - drug effects | Potassium Channel Blockers - pharmacology | Pentamidine - pharmacology | Arrhythmias, Cardiac - metabolism | Recombinant Proteins - metabolism | Shab Potassium Channels - genetics | Ether-A-Go-Go Potassium Channels - chemistry | Phenethylamines - pharmacology | Sulfonamides - chemistry | Shab Potassium Channels - chemistry | Endocytosis - drug effects | Phenethylamines - chemistry | Recombinant Proteins - chemistry | Antiprotozoal Agents - chemistry | Pentamidine - analogs & derivatives | Anti-Arrhythmia Agents - chemistry | Ether-A-Go-Go Potassium Channels - genetics | Sulfonamides - pharmacology | Antiprotozoal Agents - pharmacology | Molecular Dynamics Simulation | Shab Potassium Channels - metabolism | Animals | Antiprotozoal Agents - adverse effects | Pentamidine - chemistry | Pentamidine - adverse effects | Dogs | Mice | Kinetics | Membrane Transport Modulators - adverse effects | Potassium Channel Blockers - chemistry | Heterocyclic compounds | Analysis | Index Medicus | Research Papers
Journal Article